Genomics Personalized Health Market, Global Outlook and Forecast 2023-2029

The demand of Genomics Personalized Health is increasing owing to rise in the biopharmaceutical and healthcare industry. The other drivers for genomics personalized health the market are increase in prevalence of cancer, increase in geriatric population, increasing attentiveness towards health in emerging economies.
This report aims to provide a comprehensive presentation of the global market for Genomics Personalized Health, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomics Personalized Health. This report contains market size and forecasts of Genomics Personalized Health in global, including the following market information:
Global Genomics Personalized Health Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Genomics Personalized Health market was valued at US$ 9499.6 million in 2022 and is projected to reach US$ 16320 million by 2029, at a CAGR of 8.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
NGS Platforms Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Genomics Personalized Health include QIAGEN, Illumina, Thermo Fisher Scientific, Bio-Rad, Roche, Lonza, INVITAE, Genetic Technologies and Interleukin Genetics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genomics Personalized Health companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genomics Personalized Health Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Genomics Personalized Health Market Segment Percentages, by Type, 2022 (%)
    NGS Platforms
    RT-PCR
    Microarray
    Genetic Analyzers
Global Genomics Personalized Health Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Genomics Personalized Health Market Segment Percentages, by Application, 2022 (%)
    Academics & Research Institutes
    Diagnostic Centers
Global Genomics Personalized Health Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Genomics Personalized Health Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genomics Personalized Health revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Genomics Personalized Health revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    QIAGEN
    Illumina
    Thermo Fisher Scientific
    Bio-Rad
    Roche
    Lonza
    INVITAE
    Genetic Technologies
    Interleukin Genetics
    Eastern Biotech
    DNA Genotek
    UBiome
    XCode Life
Outline of Major Chapters:
Chapter 1: Introduces the definition of Genomics Personalized Health, market overview.
Chapter 2: Global Genomics Personalized Health market size in revenue.
Chapter 3: Detailed analysis of Genomics Personalized Health company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Genomics Personalized Health in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.